Expected value of sample information for Weibull survival data

被引:19
|
作者
Brennan, Alan [1 ]
Kharroubi, Samer A. [1 ]
机构
[1] Univ Sheffield, ScHARR, Sheffield S1 4DA, S Yorkshire, England
关键词
value of information; sample size; clinical trial design; Weibull model; proportional hazards; cost-effectiveness;
D O I
10.1002/hec.1217
中图分类号
F [经济];
学科分类号
02 ;
摘要
Expected value of sample information (EVSI) involves simulating data collection, Bayesian updating, and re-examining decisions. Bayesian updating in Weibull models typically requires Markov chain Monte Carlo (MCMC). We examine five methods for calculating posterior expected net benefits: two heuristic methods (data lumping and pseudo-normal); two Bayesian approximation methods (Tierney & Kadane, Brennan & Kharroubi); and the gold standard MCMC. A case study computes EVSI for 25 study options. We compare accuracy, computation time and trade-offs of EVSI versus study costs. Brennan & Kharroubi (B&K) approximates expected net benefits to within +/- 1% of MCMC. Other methods, data lumping (+54%), pseudo-normal (-5%) and Tierney & Kadane (+11%) are less accurate. B&K also produces the most accurate EVSI approximation. Pseudo-normal is also reasonably accurate, whilst Tierney & Kadane consistently underestimates and data lumping exhibits large variance. B&K computation is 12 times faster than the MCMC method in our case study. Though not always faster, B&K provides most computational efficiency when net benefits require appreciable computation time and when many MCMC samples are needed. The methods enable EVSI computation for economic models with Weibull survival parameters. The approach can generalize to complex multi-state models and to survival analyses using other smooth parametric distributions. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1205 / 1225
页数:21
相关论文
共 50 条
  • [1] EXPECTED VALUE OF SAMPLE INFORMATION FOR SURVIVAL DATA FROM ONGOING TRIALS
    Vervaart, Mathyn
    Aas, Eline
    Claxton, Karl
    Strong, Mark
    Welton, Nicky J.
    Wisloff, Torbjorn
    MEDICAL DECISION MAKING, 2021, 41 (04) : E343 - E344
  • [2] General Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations
    Vervaart, Mathyn
    Aas, Eline
    Claxton, Karl P.
    Strong, Mark
    Welton, Nicky J.
    Wisloff, Torbjorn
    Heath, Anna
    MEDICAL DECISION MAKING, 2023, 43 (05) : 595 - 609
  • [3] An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial
    Vervaart, Mathyn
    Strong, Mark
    Claxton, Karl P.
    Welton, Nicky J.
    Wisloff, Torbjorn
    Aas, Eline
    MEDICAL DECISION MAKING, 2022, 42 (05) : 612 - 625
  • [4] GENERAL-PURPOSE METHODS FOR SIMULATING SURVIVAL DATA FOR EXPECTED VALUE OF SAMPLE INFORMATION CALCULATIONS
    Vervaart, M.
    Heath, A.
    Aas, E.
    Claxton, K.
    Strong, M.
    Welton, N.
    Wisloff, T.
    VALUE IN HEALTH, 2022, 25 (12) : S141 - S141
  • [5] EXPECTED VALUE OF SAMPLE INFORMATION IN FACILITY LOCATION
    SHIODE, S
    ISHII, H
    NISHIDA, T
    JOURNAL OF THE OPERATIONS RESEARCH SOCIETY OF JAPAN, 1982, 25 (03) : 282 - 291
  • [6] An Efficient Estimator for the Expected Value of Sample Information
    Menzies, Nicolas A.
    MEDICAL DECISION MAKING, 2016, 36 (03) : 308 - 320
  • [7] Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial
    Heath, Anna
    Strong, Mark
    Glynn, David
    Kunst, Natalia
    Welton, Nicky J.
    Goldhaber-Fiebert, Jeremy D.
    MEDICAL DECISION MAKING, 2022, 42 (02) : 143 - 155
  • [8] Estimating Expected Value of Sample Information for Incomplete Data Models Using Bayesian Approximation
    Kharroubi, Samer A.
    Brennan, Alan
    Strong, Mark
    MEDICAL DECISION MAKING, 2011, 31 (06) : 839 - 852
  • [9] Quantifiers Induced by Subjective Expected Value of Sample Information
    Guo, Kaihong
    IEEE TRANSACTIONS ON CYBERNETICS, 2014, 44 (10) : 1784 - 1794
  • [10] Time and expected value of sample information wait for no patient
    Eckermann, Simon
    Willan, Andrew R.
    VALUE IN HEALTH, 2008, 11 (03) : 522 - 526